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1 | INTRODUC TION
Australian bat lyssavirus (ABLV) was serendipitously identified in 
1996 (Fraser et al., 1996) during active surveillance of pteropodid 
bats (flying foxes) for Hendra virus, a novel zoonotic paramyxovi‐
rus which dramatically emerged in 1994 in Australia (Murray et al., 
1995). Lyssaviruses belong to the family Rhabdoviridae, and prior 
to the description of ABLV, there were six recognised species/
genotypes: classical rabies virus (genotype 1), Lagos bat virus (geno‐
type 2), Mokola virus (genotype 3), Duvenhage virus (genotype 4), 
European bat lyssavirus 1 (genotype 5) and European bat lyssavi‐
rus 2 (genotype 6). The description of ABLV precipitated a revision 
of lyssavirus taxonomy, with genotype 7 defined to accommodate 
it (Badrane, Bahloul, Perrin, & Tordo, 2001; Gould et al., 1998). 
Sequence analysis of the ABLV nucleocapsid protein gene (used as 
the basis for genotypic classification) showed marked nucleotide and 
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Abstract
Historically, Australia was considered free of rabies and rabieslike viruses. Thus, the 
identification of Australian bat lyssavirus (ABLV) in 1996 in a debilitated bat found by 
a member of the public precipitated both public health consternation and a revision 
of lyssavirus taxonomy. Subsequent observational studies sought to elaborate the 
occurrence and frequency of ABLV infection in Australian bats. This paper describes 
the taxonomic diversity of bat species showing evidence of ABLV infection to better 
inform public health considerations. Blood and/or brain samples were collected from 
two cohorts of bats (wild‐caught and diagnostic submissions) from four Australian 
states or territories between April 1996 and October 2002. Fresh brain impression 
smears were tested for ABLV antigen using fluorescein‐labelled anti‐rabies monoclo‐
nal globulin (CENTOCOR) in a direct fluorescent antibody test; sera were tested for 
the presence of neutralising antibodies using a rapid fluorescent focus inhibition test. 
A total of 3,217 samples from 2,633 bats were collected and screened: brain samples 
from 1,461 wild‐caught bats and 1,086 submitted bats from at least 16 genera and 
seven families, and blood samples from 656 wild‐caught bats and 14 submitted bats 
from 14 genera and seven families. Evidence of ABLV infection was found in five of 
the six families of bats occurring in Australia, and in three of the four Australian 
states/territories surveyed, supporting the historic presence of the virus in Australia. 
While the infection prevalence in the wild‐caught cohort is evidently low, the signifi‐
cantly higher infection prevalence in rescued bats in urban settings represents a clear 
and present public health significance because of the higher risk of human 
exposure.
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amino acid homology (73%–74% and 92%, respectively) with classi‐
cal rabies viruses (CRV), and the ABLV phosphoprotein, matrix pro‐
tein and glycoprotein genes also show a closer sequence homology 
to CRV than to the other lyssaviruses (Gould et al., 1998). Further, 
ABLV and CRV share the same serotype (1), with cross‐neutralisation 
evident against 19 of a panel of 21 monoclonal antibodies (Gould 
et al., 1998). Rabies vaccine and anti‐rabies immunoglobulin protect 
laboratory animals from ABLV infection (Hooper et al., 1997) and are 
evidently equally effective in humans, although Brookes, Parsons, 
Johnson, McElhinney, and Fooks (2005) suggest that maximum vac‐
cine efficacy against ABLV (and other non‐RABV lyssaviruses) may 
require a higher virus‐neutralising antibody threshold. Two vari‐
ants of ABLV have been described, with isolates from pteropodid 
bats (Pteropus spp.) and yellow‐bellied sheathtail bats (Saccolaimus 
flaviventris) falling into two distinct clades by sequence analysis 
(Gould, Kattenbelt, Gumley, & Lunt, 2002; Gould, Kattenbelt, Hyatt, 
Gumley, & Lunt, 1999; Warrilow, Smith, Harrower, & Smith, 2002).
Historically, Australia was considered free of rabies and rabieslike 
viruses. Rhabdoviruses from the genus Ephemerovirus were known to 
occur (e.g.,Bovine ephemeral fever, Adelaide River virus), but none 
from the genus Lyssavirus had been described. Prophetically, St George 
(1989), postulating the origins of Adelaide River virus, suggested the 
possibility of an undiscovered rabieslike virus in Australian bats. St. 
George went further, suggesting that the typically low prevalence of 
lyssavirus infections in bats meant that an Australian bat lyssavirus 
might not become evident unless active surveillance was undertaken 
or unless a human or a domestic animal was infected by a bat.
Within 6 months of the identification of ABLV in flying foxes, the 
zoonotic capability of the virus became evident when a wildlife carer 
in central Queensland developed a fatal rabies illness in October 
1996 (Allworth, Murray, & Morgan, 1996). A second fatal human 
case occurred in December 1998, 27 months after a bite from a fly‐
ing fox (Hanna et al., 2000). These cases precipitated an aggressive 
public heath campaign promoting avoidance of bat contact and ra‐
bies vaccination for vocationally at‐risk people. No further human 
cases were reported until 2012 when a young boy contracted a 
fatal infection following unsolicited contact with a bat (Francis et al., 
2014). This tragic case reignited public and media interest in ABLV, 
which was further promoted by two related equine cases in 2013 
(Shinwari et al., 2014).
This paper presents the findings of observational studies which 
investigated the occurrence and frequency of ABLV infection in 
Australian bats. The primary aim was to scope the taxonomic diver‐
sity of bat species showing evidence of infection to inform public 
health considerations.
2  | METHODS
2.1 | Animal ethics
Fieldwork was approved under the (then) Queensland Government 
Department of Primary Industries and the Western Australian 
Government Department of Conservation and Land Management 
Animal Ethics Committee permits Bribie/31/00 and CAEEC11/98, 
respectively. All capture events and all methods (detailed below) 
were specifically approved under the permits. All capture, handling, 
anaesthesia and euthanasia were undertaken by or directly super‐
vised by an experienced veterinarian.
2.2 | Sample characteristics
Blood and/or brain samples were collected from bats in the Australian 
states of Queensland, New South Wales and Western Australia, and 
the Northern Territory between April 1996 and October 2002 (Field, 
2005). Samples were obtained from two cohorts of bats: actively 
sampled and evidently healthy free‐living bats (hereafter referred 
to as “wild‐caught” bats) and sick, injured or recently dead bats 
submitted to the Queensland Government veterinary laboratory in 
Brisbane for diagnostic testing (“submitted” bats). Wild‐caught bats 
were typically captured in mist nets or harp traps between dusk and 
dawn, either as they left or returned to their roost or as they foraged 
(Epstein & Field, 2011). Bats from which only blood was taken were 
typically sampled under inhalation anaesthetic (Jonsson, Johnston, 
Field, Jong, & Smith, 2004) with individuals released at the point of 
capture within four hours. Bats from which brain (or brain and blood) 
samples were taken were humanely euthanised immediately prior 
to sampling: larger bats (Pteropodidae and Megadermatidae) by a 
lethal dose of barbiturate (Lethabarb®, 325 mg/ml pentobarbitone 
sodium, Virbac) intravenously or (diluted 1:3) intraperitoneally and 
smaller bats (Hipposideridae and Vespertilioniformes) by the inha‐
lation of CO2. Event and individual animal data including location, 
date, genus/species, sex and age were recorded.
2.3 | Test characteristics
Fresh brain impression smears were tested for ABLV antigen 
at the Queensland Government veterinary laboratory using 
Impacts
• With Australia historically considered free of lyssavi‐
ruses, the emergence/detection of Australian bat lyssa‐
virus (ABLV) posed a risk management challenge in a 
(then) naïve public and public health landscape.
• Numerous bat taxa have a regular urban presence in 
Australia, and well‐meaning members of the public reg‐
ularly “rescue” sick and injured bats for rehabilitation 
through an established carer network.
•  While the ABLV infection prevalence in wild‐caught 
bats is low, the significantly higher infection prevalence 
in rescued sick and injured bats represents a clear and 
present public health danger because of the higher risk 
of human exposure.
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fluorescein‐labelled anti‐rabies monoclonal globulin (CENTOCOR) 
in a direct fluorescent antibody test (FAT). Smears were made from 
at least three sites (medulla, cerebellum and hippocampus) on the 
cut brain surface. Antigen detection provides direct evidence of cur‐
rent infection.
Sera were forwarded to the Australian Animal Health Laboratory 
(AAHL) in Geelong for testing for the presence of neutralising anti‐
bodies using the rapid fluorescent focus inhibition test (RFFIT), as 
reported by Smith, Yager, and Baer (1973). Briefly, the method en‐
tails infecting BHK‐21 cells with a tissue culture‐adapted rabies virus 
(CVS‐11). Subsequently, an equal volume of challenge virus is added 
to serum dilutions, and after 24 hr of incubation, the number of fluo‐
rescing fields counted. The criterion for positivity was a 50% reduc‐
tion in infectious centres relative to a positive (NIH reference serum) 
control. Given the absence of classical rabies or other serotype 1 
lyssaviruses in Australia, this assay provided a practical screening 
test while a specific ABLV RFFIT was being developed. Antibody 
detection provides indirect evidence of past exposure or infection.
2.4 | Analysis
Descriptive summary statistics are used to describe the data. Within 
sample cohorts, 95% confidence intervals are used to indicate signifi‐
cant difference. Sparse data precluded definitive statistical analyses.
3  | RESULTS
A total of 3,217 brain and/or blood samples were collected from 2,633 
bats (Figure 1). Brain samples were collected from 2,547 bats, being 
1,461 wild‐caught bats (Table 1) and 1,086 submitted bats (Table 2). 
Individuals from at least 16 genera and seven families (44 submitted 
F I G U R E  1   Composition of a sample 
of 2,633 bats screened for ABLV antigen 
and/or antibody
2,633
Total
1,533
Wild-caught
603
Pteropodiformes
930
Vesperlioniformes
1,100
Submied
924
Pteropodiformes
176
Vesperlioniformes
TA B L E  1   Australian bat lyssavirus surveillance in 1,5331 wild‐caught bats in Queensland, Western Australia and the Northern Territory 
between April 1996 and October 2002
Suborder Family Genus
Antigen detection (FAT) Antibody detection (RFFIT)
Number tested
Number (%, 95% 
CI) positive
Number 
tested
Number (%, 95% CI) 
positive
Pteropodiformes Pteropodidae Pteropus 475 0 266 8 (3.0, 1.5–5.8)
Megadermatidae Macroderma 0 0 68 1 (1.5, 0.3–7.9)
Hipposideridae Hipposideros 30 0 30 1 (3.3, 0.6–16.7)
Vespertilioniformes Mollosidae Chaerophon 4 0 2 1 (50.0, 9.5–90.6)
Mormopterus 236 0 3 0
Tadarida 45 0 45 1 (2.2, 0.4–11.6)
Vespertilionidae Chalinolobus 61 0 55 2 (3.6, 1.0–12.3)
Myotis 34 0 14 0
Nyctophilus 2 0 1 0
Scotorepens 64 0 2 0
Vespedalus 51 0 45 1 (2.2, 0.4–11.6)
Miniopteridae Miniopterus 393 0 60 0
Emballonuridae Saccolaimus 26 0 24 3 (12.5, 4.4–31.0)
Taphozous 40 0 41 0
Total 1,461 0 656 18 (2.7, 1.7–4.3)
Some bats (266 Pteropodiformes and 318 Vespertilioniformes) yielded both brain and blood samples, reflected in the total number of 2,117 tests.
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bats were unidentified) and both chiropteran suborders were sampled, 
with a median genus sample size of 26.5 (range 2–902). Antigen was not 
detected in any wild‐caught bat, but was detected in 74 (6.8%) submit‐
ted bats from two genera and four species: Pteropus alecto, Pteropus 
poliocephalus, Pteropus scapulatus and S. flaviventris (Table 3).
Blood samples were collected from 670 bats, being 656 wild‐
caught bats (Table 1) and 14 submitted bats (Table 2). Individuals 
from 14 genera, seven families and both suborders were sampled 
(Table 2), with a median genus sample size of 27 (range 1–266). 
Antibody was detected in 18 (2.7%) wild‐caught bats and four 
(28.6%) submitted bats from eight genera, six families and both sub‐
orders (Table 3). Antibody prevalence in genera in which antibody 
was detected ranged from 1.5% to 50% (median = 3.3%). Two sub‐
mitted bats (one P. alecto and one P. poliocephalus) from which brain 
and blood were sampled tested positive for both antibody and anti‐
gen (Table 2).
4  | DISCUSSION
Despite its first description in 1996, there has been limited investi‐
gation of the eco‐epidemiology of ABLV in Australian bats (Barrett, 
2004; Field, 2005). This report shows that ABLV is taxonomically 
widespread in Australian bats, with evidence of infection found 
in five of the six families present. The detection of either antigen 
or antibody in bats in three of the four states/territories surveyed 
further supports the historic presence of the virus in Australia, as 
the taxonomic and geographical scale of detections is epidemiologi‐
cally inconsistent with recent introduction. The lack of detections in 
NSW likely reflects the limited number of samples from that state. 
However, the findings indicate that at the population level, infection 
prevalence is low, with viral antigen not detected in the wild‐caught 
cohort notwithstanding reasonably large sample sizes in some taxa 
known (from submitted samples) to be susceptible to infection. In 
Pteropus spp. for example, with a sample size of 475, this translates 
to an estimated “background” infection prevalence in wild popula‐
tions of <0.5%. That ABLV causes clinical disease, debilitation and 
death in bats means that infected bats are over‐represented in the 
submitted bat cohort, with such individuals more likely to be found 
and submitted than healthy bats. With many such submissions being 
debilitated bats found in urban backyards, the higher infection prev‐
alence in this cohort (e.g., 7.6% in Pteropus spp.) has direct public 
health significance because of the higher risk of human exposure.
Antigen detection was significantly higher in the genus 
Saccolaimus (S. flaviventris) than in all other genera, while P. scapula-
tus had a significantly higher antigen prevalence than other Pteropus 
species. From a public health perspective, these findings suggest that 
these two species pose a heightened exposure risk. The lack of anti‐
gen detection in Vespertilioniformes other than S. flaviventris may in 
part reflect their typically smaller size, which makes them less readily 
detected by members of the public, meaning that relatively few are 
submitted. The lack of a positively biased sample is a fundamental 
TA B L E  2   Australian bat lyssavirus surveillance in 1,100 submitted bats in Queensland and New South Wales between June 1996 and 
March 2002
Suborder Family Genus
Antigen detection (FAT) Antibody detection (RFFIT)
Number tested
Number (%, 95% 
CI) positive Number tested
Number (%, 95% CI) 
positive
Pteropodiformes Pteropodidae Pteropusa 902 69 (7.7, 6.1–9.6) 14 4b (28.6, 11.7–54.7)
Nyctimene 2 0 0 0
Syconycteris 6 0 0 0
Vespertilioniformes Mollosidae Mormopterus 19 0 0 0
Vespertilionidae Chalinolobus 22 0 0 0
Myotis 2 0 0 0
Nyctophilus 24 0 0 0
Scotorepens 22 0 0 0
Vespedalus 4 0 0 0
Miniopteridae Miniopterus 29 0 0 0
Emballonuridae Saccolaimusc 8 5 (62.5, 
30.6–86.3)
0 0
Taphozous 2 0 0 0
Unidentified 44 0 0 0
Total 1,086 74 (6.8, 5.5–8.5) 14 4 (28.6, 11.7–54.7)
Note. aAntigen detection in Pteropus alecto = 37/481 (7.7%), P. conspicillatus = 1/95 (1%), Pteropus  poliocephalus = 9/200 (4.5%), Pteropus scapula-
tus = 22/126 (17.4%).  
bTwo bats tested positive for both antibody and antigen.  
cSaccolaimus flaviventris.
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impediment to the direct detection of infection in these species 
and to a more complete elaboration of the ecology and phylogeny 
of ABLV in Australian bats. That said, it appears evident from the 
findings that Pteropus spp. and S. flaviventris play an important role 
in the ecology of ABLV. This is supported by phylogenetic analyses 
to date, which identify two distinct virus clades reflecting sequence 
variation in Pteropus spp. and S. flaviventris isolates (Warrilow et al., 
2002). Given bat diversity in Australia, it is probable that targeted 
surveillance will reveal further diversity. Such surveillance might 
usefully focus on the Mollosidae and Vespertilionidae, both of which 
had multiple genera in which antibodies were detected.
Generically, antibodies provide indirect evidence of past ex‐
posure or infection. However, serology has been an irrelevant 
lyssavirus surveillance tool in nonbat species because of a near 
100% case fatality rate. The putative adapted ancestral reservoir 
of lyssaviruses (Badrane & Tordo, 2001), bats are the only taxa in 
which antibodies are detected with sufficient frequency to support 
serosurveillance. The crude antibody prevalence in wild‐caught 
bats in this study was 18%. Some taxa yielded high antibody prev‐
alence in very small sample sizes; conversely, no antibodies were 
detected in Miniopterus notwithstanding a reasonably large sam‐
ple size across multiple locations and times. Arguin et al. (2002) 
reported an anti‐ABLV antibody prevalence of 9.5% (22/231) in a 
multigenera sample of Philippine bats (including Miniopterus) using 
a RFFIT with a specific ABLV antigen. The detection of only five 
antibody‐positive individuals in a parallel RFITT using rabies virus 
Suborder Family Genus
No. of bats tested 
positive
by FAT by RFFIT
Pteropodiformes Hipposideridae Hipposideros 1
Megadermatidae Macroderma 1
Pteropodidiae Pteropus 69 12
Vespertilioniformes Emballonuridae Saccolaimus 5 3
Molossidae Chaerophon 1
Tadarida 1
Vespertilionidae Vespedalus 1
Chalinolobus 2
Sex
Male 34 7
Female 32 14
Unknown 8 1
Age
Immature 12 4
Mature 51 11
Unknown 11 7
Sample method
Wild‐caught 18
Submitted 74 4
Sample location
Northern Territory 5
Queensland 74 4
Western Australia 13
Sample year
1996 6 2
1997 24 1
1998 23 6
1999 4
2000 9
2001 5 13
2002 3
Total 74 22
TA B L E  3   Characteristics of 96 bats of 
the total 2,633 surveyed that showed 
evidence of Australian bat lyssavirus 
infection either by FAT or by RFFIT
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antigen suggests that the latter has a sensitivity of only 23% relative 
to the ABLV RFFIT, at least on the virus circulating in the Philippine 
bats. Thus, notwithstanding the different criteria for positivity in 
Arguin et al. (2002) (90% or greater reduction in infectious centres 
versus 50% in the AAHL assay), it is probable that serologic inves‐
tigations in Australian bats using rabies virus RFITT underestimate 
ABLV antibody prevalence.
The difficulty in detecting infections with a short clinical course, 
high case fatality rate and low prevalence in wild populations using 
a cross‐sectional study design are well recognised. As discussed 
above, screening a positively biased sample is one approach to the 
challenge, but while useful to establish presence, it can constrain 
understanding of the characteristics of the infection at the pop‐
ulation level. An alternative is to increase sample size, but where 
the test requires destructive sampling (as for lyssavirus FAT), this 
alternative is untenable from both an ethical and a resource stand‐
point; statistically, to detect an infected individual at say 0.1% in‐
fection prevalence would necessitate the capture and destruction 
of 1,000 individuals. In bats, serology offers a larger surveillance 
“window” because of the typically persistent nature of antibodies. 
Whether anti‐lyssavirus antibodies represent noninfectious expo‐
sure, subclinical “aborted” infection, pending clinical infection or 
recovered infection is unclear and contentious, but in the context 
of this study, it is also irrelevant. Detection of antibodies in this 
study is interpreted as evidence of ABLV “infection” at a popula‐
tion level rather than the status of an individual bat. Nonetheless, 
serosurveillance has limitations in that the absence of detection of 
antibodies cannot be interpreted as the absence of susceptibility to 
infection of taxa, and prevalence comparisons across taxa are not 
valid in the absence of relative case fatality rates. Finally, serology 
does not allow identification of the current infection status of an 
individual nor provide antigenic material to support molecular epi‐
demiology studies.
In conclusion, there is direct or indirect evidence of ABLV infec‐
tion in diverse and geographically widespread Australian bat taxa, 
consistent with an historic presence in the landscape. While the in‐
fection prevalence in wild populations is evidently low, the findings 
suggest that some species have a higher likelihood of infection, al‐
though this interpretation should be constrained by the nonrandom 
nature of the sampling and the varying sample sizes. Nonetheless, it 
is evident that the submitted bat cohort (comprising bats rescued by 
members of the public) poses a substantially higher ABLV exposure 
risk from a human health perspective. The enduring messaging from 
both animal and human health authorities in Australia is for members 
of the public to avoid direct contact with all bats, to call registered 
and vaccinated wildlife carers to rescue a bat and to seek immediate 
medical advice should direct contact occur.
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